In a large U.S. retrospective cohort study published in JAMA Network Open, investigators report that glucagon-like peptide-1 ...

Treatment with incretin-based weight-loss medications, like GLP-1 receptor agonists, after bariatric surgery was associated with significantly lower risks of alcohol use disorder (AUD) and initiation ...

Researchers are studying whether these widely used weight-loss drugs may also be future treatments for alcohol abuse.

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...

About one in eight American adults say they’ve used a GLP-1 receptor agonist medication like Ozempic or Wegovy at some point, ...

The best weight loss medication for men includes semaglutide (Ozempic , Wegovy ), tirzepatide (Mounjaro , Zepbound ), and ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to approaching the brain-wasting disease as a system of complex pathways, much ...

Blood and genetic tests to accurately identify biomarkers of the disease are becoming available, but most diagnoses require a ...

Certain people who use cannabis tend to drink less alcohol, a new study found. Researchers from Brown University’s Center for Alcohol and Addiction Studies set out to determine whether cannabis use ...

Vanda Pharmaceuticals said its investigational neurokinin-1 receptor antagonist tradipitant reduced nausea and vomiting from semaglutide (Ozempic, Wegovy) in a randomized trial of people with obesity ...

Characterized by compulsive drinking, loss of control, and negative emotional states when not using, alcohol use disorder (AUD) was recently linked to dementia. Despite advances in neuroscience and ...

Please provide your email address to receive an email when new articles are posted on . There are limited numbers of FDA-approved medications to treat alcohol and substance use disorders. Preclinical ...